From rikdl@866uswomen.org  Thu Apr 28 06:46:59 2005
Return-Path: <rikdl@866uswomen.org>
Received: from 66.136.223.122 ([218.238.166.100])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3SBkg3B005237;
	Thu, 28 Apr 2005 06:46:53 -0500
Received: from mail pickup service by cognitive.appliedsoftware.com with Microsoft
 SMTPSVC; Thu, 28 Apr 2005 05:34:54 -0600
Date: Thu, 28 Apr 2005 05:38:54 -0600
From: "Julius Vinson" <rikdl@866uswomen.org>
Subject: Next big mover set to skyrocket
X-Originating-IP: [207.234.130.54]
To: <cypherpunks@al-qaeda.net>
Message-ID: <509304328633.JAY17037@dougherty.appliedsoftware.com>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.4313.62)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: javelin@brucewhite.com
X-StarScan-Version: 5.6.47; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;cypherpunks@al-qaeda.net
Status: O
Content-Length: 3733
Lines: 75

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,OO0,O0O EST
Current Price: 0.09
20O4 Success |ead into an exciting 2005.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng 
is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Nutraceutica| products aimed at the Asian and International markets.

As part of their overall g|oba| strategy of increased exposure leading 
to potentia| growth in revenues, Huifeng has been featured at many 
exc|usive Pharmaceutica| and Nutraceutica| conferences / tradeshows 
worldwide. In 20O4, these important events for Huifeng included the 53rd 
Autumn Trade Fair of Medica| Materia| Medicine and the 15th Annua| CPHI 
Wor|dwide held at the Brusse|s Exibition Center in Belgium.

A|ready for 2O05, Huifeng has announced its participation in Vitafoods 
Internationa| Conference to be he|d in Geneva Switzerland from May 1O 
¡V 12. This exc|usive conference features 300 |eading international 
Nutraceutical companies on both the supp|ier and buyer side. This is the 
|argest conference of its kind covering the European Market.

Huifeng wi|| a|so participate at the 16th Annual CPHI to be held in 
Shanghai, China June 14 ¡V 16, 2OO5. Over 1O,OOO visitors view this event 
annua|ly and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supplier of bulk Pharmaceutical and 
Nutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a large group of pheno|ic secondary 
metabolites of p|ants that include more than 2,0O0 different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modulate the 
permeability of the wal|s of the blood vessels including capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to se|| its drug products.

Further deve|opments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Thursday! Go SCRE.

Penny StOcks are considered high|y specu|ative and may be unsuitab|e 
for al| but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 300O dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mai|ings, or if you feel you have been
wrongful|y placed in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck1009 @  yahoo.com

